ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,434Medicare Part D Prescriptions Filled, Including Refills

Rank: 369 out of 5176

$789K Total Retail Price of All Prescriptions

Rank: 466 out of 5176

224 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 11,163 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

56 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
WARFARIN SODIUM 619 523 1 13
OMEPRAZOLE 453 427 2 3
DONEPEZIL HCL 392 379 3 28
LEVOTHYROXINE SODIUM 379 323 4 4
METOPROLOL TARTRATE 330 296 5 6
POTASSIUM CHLORIDE 317 290 6 34
AMLODIPINE BESYLATE 276 253 7 2
FUROSEMIDE 253 244 8 8
LISINOPRIL 252 215 9 5
KLOR-CON M20 223 215 10 129
CITALOPRAM HBR 219 213 11 31
LANTUS 194 188 12 66
LIDOCAINE 186 170 13 179
TRAZODONE HCL 185 158 14 71
NAMENDA 178 171 15 47
SIMVASTATIN 150 117 16 1
TAMIFLU 148 136 17 231
POLYETHYLENE GLYCOL 3350 137 129 18 74
METOPROLOL SUCCINATE 135 134 19 11
GLIPIZIDE 133 123 20 63
DIVALPROEX SODIUM 132 115 21 104
CIPROFLOXACIN HCL 131 122 22 84
NOVOLIN R 128 124 23 191
QUETIAPINE FUMARATE 128 106 23 75
IPRATROPIUM-ALBUTEROL 126 121 25 138
RISPERIDONE 118 98 26 78
GABAPENTIN 117 100 27 21
SUCRALFATE 116 112 28 303
CYMBALTA 113 91 29 90
OLANZAPINE 109 101 30 140
CEPHALEXIN 109 104 30 189
HALOPERIDOL 108 76 32 145
SERTRALINE HCL 107 107 33 30
AVELOX 104 92 34 352
METFORMIN HCL 95 70 35 7
ISOSORBIDE MONONITRATE ER 93 92 36 44
LEVETIRACETAM 92 62 37 92
ALBUTEROL SULFATE 89 85 38 99
TRAMADOL HCL 89 86 38 40
IPRATROPIUM BROMIDE 86 82 40 135
SULFAMETHOXAZOLE-TRIMETHOPRIM 82 76 41 181
CLOTRIMAZOLE-BETAMETHASONE 77 71 42 94
MIRTAZAPINE 76 70 43 45
SANTYL 74 67 44 124
ADVAIR HFA 74 71 44 330
HYDROCHLOROTHIAZIDE 72 51 46 10
CARVEDILOL 72 70 46 24
CLOPIDOGREL 72 71 46 26
AZITHROMYCIN 69 63 49 42
PANTOPRAZOLE SODIUM 68 68 50 61
ATORVASTATIN CALCIUM 67 64 51 9
CARBAMAZEPINE 65 40 52 302
MUPIROCIN 65 63 52 182
DIGOXIN 62 62 54 56
AMPICILLIN TRIHYDRATE 61 56 55 504
VENLAFAXINE HCL ER 60 60 56 186
COMBIVENT 59 49 57 156
OXYBUTYNIN CHLORIDE 56 52 58 227
OXCARBAZEPINE 53 43 59 379
GLYBURIDE 52 52 R 60 67
BENZTROPINE MESYLATE 51 30 R 61 201
SPIRIVA 50 36 62 54
TAMSULOSIN HCL 50 47 62 20
SEROQUEL 50 38 62 166
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 12, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.